Delivery Order SPE2DB22D2005-SPE2DB24FJLR2

Award Date 4/23/24
Potential Completion Date 4/24/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product, to the U.S. government. The contract, valued at $37,595.72, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The $56,637.48 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $31,352.85 for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price pricing type and a period of performance through April 10, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of DIFICID 200 MG TABLET 20S to the Defense Logistics Agency (DLA). The $23,091.08 firm fixed-price delivery order has a period of performance through February 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,664.55 delivery order is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product, with a performance period through December 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of DIFICID 200 MG TABLET 20S. The $10,419.42 firm fixed price delivery order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product, to the Department of Defense (DOD). The contract, valued at $36,329.52, is a firm fixed-price delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, worth up to $999,999,999.00 through December 31, 2025, serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4564542342 - DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract, awarded by the Defense Logistics Agency (DLA), is a $19,226.22 Firm Fixed Price Delivery Order with a completion date of May 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award, valued at $12,131.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,755.67 for the supply of DIFICID 200 MG TABLET 20S. The contract, which has a Firm Fixed Price pricing type, was awarded on June 7, 2024 by the Defense Logistics Agency (DLA), a major logistics and supply agency within the Department of Defense (DoD). The contract has an ultimate completion date of June 10, 2024 and does not have a set-aside designation. Amerisourcebergen, a...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJLR2
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $12,237.25 Firm Fixed Price delivery order to supply the pharmaceutical product DIFICID 200 MG TABLET 20S to the Defense Logistics Agency (DLA). The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 7/23/24, 10:45 AM